CMap Candidates
CMap (Connectivity Map) candidates are extracted from CLUE (CMap and LINCS Unified Environment), with detailed information, e.g., perturbagen time and dose, compound structure, targets, SMILES, mechanism of action. Two publicly available gene expression profiles of NAFLD are used to calculate individual connectivity scores and corresponding statistical significances for these candidates.
stats1
stats2
34330 records.
| CMap ID | Pert ID | Compound Name | Targets | MoA | Compound Aliases | |
|---|---|---|---|---|---|---|
| C23604 | BRD-K66700691 | BRD-K66700691 | -- | -- | -- | Details |
| C23605 | BRD-K66703091 | BRD-K66703091 | -- | -- | -- | Details |
| C23606 | BRD-K66707493 | lawsone | -- | -- | -- | Details |
| C23607 | BRD-K66707905 | BRD-K66707905 | -- | -- | -- | Details |
| C23608 | BRD-K66708851 | BRD-K66708851 | -- | -- | -- | Details |
| C23609 | BRD-K66710853 | BRD-K66710853 | -- | -- | -- | Details |
| C23610 | BRD-K66714409 | BRD-K66714409 | -- | -- | -- | Details |
| C23611 | BRD-K66715657 | BRD-K66715657 | -- | -- | UH-232-(+) | Details |
| C23612 | BRD-K66717300 | BRD-K66717300 | -- | -- | -- | Details |
| C23613 | BRD-K66729212 | BRD-K66729212 | -- | -- | -- | Details |
| C23614 | BRD-K66729666 | BRD-K66729666 | -- | -- | -- | Details |
| C23615 | BRD-K66732164 | BRD-K66732164 | -- | -- | -- | Details |
| C23616 | BRD-K66732564 | BRD-K66732564 | -- | -- | -- | Details |
| C23617 | BRD-K66733186 | BRD-K66733186 | -- | -- | -- | Details |
| C23618 | BRD-K66734120 | BRD-K66734120 | -- | -- | -- | Details |
| C23619 | BRD-K66735533 | BRD-K66735533 | -- | -- | -- | Details |
| C23620 | BRD-K66735566 | BRD-K66735566 | -- | -- | -- | Details |
| C23621 | BRD-K66740714 | BRD-K66740714 | -- | -- | -- | Details |
| C23622 | BRD-K66748326 | BRD-K66748326 | -- | -- | -- | Details |
| C23623 | BRD-K66750772 | BRD-K66750772 | -- | -- | -- | Details |
| C23624 | BRD-K66754362 | BRD-K66754362 | -- | -- | -- | Details |
| C23625 | BRD-K66755238 | BRD-K66755238 | -- | -- | -- | Details |
| C23626 | BRD-K66757073 | BRD-K66757073 | -- | -- | -- | Details |
| C23627 | BRD-K66757832 | BRD-K66757832 | -- | -- | -- | Details |
| C23628 | BRD-K66761585 | BRD-K66761585 | -- | -- | -- | Details |
| C23629 | BRD-K66762690 | BRD-K66762690 | -- | -- | -- | Details |
| C23630 | BRD-K66763349 | STOCK1S-03920 | -- | -- | STOCK-1S-03920 | Details |
| C23631 | BRD-K66766661 | BRD-K66766661 | -- | -- | 17-beta-estradiol | Details |
| C23632 | BRD-K66771647 | BRD-K66771647 | -- | -- | -- | Details |
| C23633 | BRD-K66775134 | BRD-K66775134 | -- | -- | -- | Details |
| C23634 | BRD-K66782112 | ICI-162846 | HRH2 | Histamine receptor antagonist | -- | Details |
| C23635 | BRD-K66783461 | BRD-K66783461 | -- | -- | -- | Details |
| C23636 | BRD-K66788707 | fludarabine | RRM1 | DNA synthesis inhibitor | -- | Details |
| C23637 | BRD-K66792149 | quinoclamine | -- | -- | -- | Details |
| C23638 | BRD-K66793411 | BRD-K66793411 | -- | -- | -- | Details |
| C23639 | BRD-K66802550 | BRD-K66802550 | -- | -- | -- | Details |
| C23640 | BRD-K66803141 | BRD-K66803141 | -- | -- | -- | Details |
| C23641 | BRD-K66805710 | BRD-K66805710 | -- | -- | -- | Details |
| C23642 | BRD-K66807670 | BRD-K66807670 | -- | -- | -- | Details |
| C23643 | BRD-K66808046 | oxyquinoline | -- | -- | -- | Details |
| C23644 | BRD-K66808842 | BRD-K66808842 | -- | -- | -- | Details |
| C23645 | BRD-K66809950 | BRD-K66809950 | -- | -- | -- | Details |
| C23646 | BRD-K66812281 | BRD-K66812281 | -- | -- | -- | Details |
| C23647 | BRD-K66814954 | BRD-K66814954 | -- | -- | -- | Details |
| C23648 | BRD-K66818636 | lomifylline | -- | -- | -- | Details |
| C23649 | BRD-K66821167 | BRD-K66821167 | -- | -- | -- | Details |
| C23650 | BRD-K66823946 | BRD-K66823946 | -- | -- | -- | Details |
| C23651 | BRD-K66830666 | BAZ2-ICR | -- | -- | BAZ-2-ICR | Details |
| C23652 | BRD-K66831269 | BRD-K66831269 | -- | -- | -- | Details |
| C23653 | BRD-K66836247 | BRD-K66836247 | -- | -- | -- | Details |
| C23654 | BRD-K66838288 | BRD-K66838288 | -- | -- | -- | Details |
| C23655 | BRD-K66838902 | BRD-K66838902 | -- | -- | -- | Details |
| C23656 | BRD-K66841501 | BRD-K66841501 | -- | -- | -- | Details |
| C23657 | BRD-K66847579 | WZ-7043 | CSF1R | CSF1R inhibitor | -- | Details |
| C23658 | BRD-K66848791 | BRD-K66848791 | -- | -- | -- | Details |
| C23659 | BRD-K66850406 | BRD-K66850406 | -- | -- | -- | Details |
| C23660 | BRD-K66852478 | BRD-K66852478 | -- | -- | -- | Details |
| C23661 | BRD-K66857089 | BRD-K66857089 | -- | -- | -- | Details |
| C23662 | BRD-K66857873 | BRD-K66857873 | -- | -- | -- | Details |
| C23663 | BRD-K66860235 | BRD-K66860235 | -- | -- | -- | Details |
| C23664 | BRD-K66865641 | BRD-K66865641 | -- | -- | -- | Details |
| C23665 | BRD-K66866270 | BRD-K66866270 | -- | -- | -- | Details |
| C23666 | BRD-K66866904 | BRD-K66866904 | -- | -- | -- | Details |
| C23667 | BRD-K66868536 | BRD-K66868536 | -- | -- | -- | Details |
| C23668 | BRD-K66870022 | BRD-K66870022 | -- | -- | -- | Details |
| C23669 | BRD-K66874953 | pifithrin-alpha | TP53 | TP53 inhibitor | -- | Details |
| C23670 | BRD-K66876909 | linezolid | MAOA; MAOB | Bacterial 50S ribosomal subunit inhibitor | -- | Details |
| C23671 | BRD-K66877406 | BRD-K66877406 | -- | -- | -- | Details |
| C23672 | BRD-K66879977 | BRD-K66879977 | -- | -- | -- | Details |
| C23673 | BRD-K66883387 | BRD-K66883387 | -- | -- | -- | Details |
| C23674 | BRD-K66884694 | BRD-K66884694 | -- | -- | -- | Details |
| C23675 | BRD-K66888355 | BRD-K66888355 | -- | -- | -- | Details |
| C23676 | BRD-K66889220 | BRD-K66889220 | -- | -- | -- | Details |
| C23677 | BRD-K66896231 | ipidacrine | ACHE | Acetylcholinesterase inhibitor | -- | Details |
| C23678 | BRD-K66896657 | BRD-K66896657 | -- | -- | -- | Details |
| C23679 | BRD-K66896751 | alpidem | -- | -- | -- | Details |
| C23680 | BRD-K66898048 | BRD-K66898048 | -- | -- | -- | Details |
| C23681 | BRD-K66898851 | sanguinarium-chloride | CASP3 | FtsZ inhibitor; Apoptosis stimulant; Caspase activator; Acetylcholinesterase inhibitor; Rho associated kinase inhibitor | -- | Details |
| C23682 | BRD-K66902379 | BRD-K66902379 | -- | -- | -- | Details |
| C23683 | BRD-K66907139 | BRD-K66907139 | -- | -- | -- | Details |
| C23684 | BRD-K66908362 | BRD-K66908362 | -- | -- | -- | Details |
| C23685 | BRD-K66909449 | BRD-K66909449 | -- | -- | -- | Details |
| C23686 | BRD-K66909712 | BRD-K66909712 | -- | -- | -- | Details |
| C23687 | BRD-K66910993 | BRD-K66910993 | -- | -- | -- | Details |
| C23688 | BRD-K66911501 | MK-3207 | CALCRL; CALCA | Calcitonin antagonist | -- | Details |
| C23689 | BRD-K66912462 | BRD-K66912462 | -- | -- | -- | Details |
| C23690 | BRD-K66925231 | BRD-K66925231 | -- | -- | -- | Details |
| C23691 | BRD-K66937583 | lodoxamide | -- | -- | -- | Details |
| C23692 | BRD-K66939340 | BRD-K66939340 | -- | -- | -- | Details |
| C23693 | BRD-K66941670 | BRD-K66941670 | -- | -- | -- | Details |
| C23694 | BRD-K66944475 | BRD-K66944475 | -- | -- | -- | Details |
| C23695 | BRD-K66944906 | fraxidin | CA12 | Carbonic anhydrase inhibitor | -- | Details |
| C23696 | BRD-K66947316 | BRD-K66947316 | -- | -- | -- | Details |
| C23697 | BRD-K66952385 | SA-102096 | -- | -- | -- | Details |
| C23698 | BRD-K66954388 | BRD-K66954388 | -- | -- | -- | Details |
| C23699 | BRD-K66955555 | BRD-K66955555 | -- | -- | -- | Details |
| C23700 | BRD-K66956375 | oleoylethanolamide | GPR119; PPARA | PPAR receptor agonist; Potassium channel blocker; Cannabinoid receptor agonist; Glucose dependent insulinotropic receptor agonist | -- | Details |
| C23701 | BRD-K66960754 | BRD-K66960754 | -- | -- | -- | Details |
| C23702 | BRD-K66963616 | BRD-K66963616 | -- | -- | -- | Details |
| C23703 | BRD-K66963756 | BRD-K66963756 | -- | -- | -- | Details |